Olr905 inhibitors are a distinct class of chemical compounds that specifically target and modulate the function of the Olfactory Receptor 905 (Olr905). These receptors belong to the extensive G protein-coupled receptor (GPCR) family, which plays a pivotal role in the olfactory system by detecting and transducing odorant molecules into neuronal signals. The inhibition of Olr905 involves compounds that can bind to this receptor, altering its conformational state and thereby affecting its ability to interact with natural ligands. This process is crucial in understanding the intricate mechanisms of olfactory signal transduction and the overall sensory perception in organisms.
Chemically, Olr905 inhibitors can vary significantly in their molecular structure, ranging from small organic molecules to more complex entities. These inhibitors are designed to fit precisely within the binding pocket of Olr905, often mimicking the structural characteristics of the receptor's natural ligands but with modifications that impede receptor activation. The study of these inhibitors provides valuable insights into the structural dynamics of Olr905, as well as the broader GPCR family. By examining the interactions between Olr905 and its inhibitors through techniques like X-ray crystallography and molecular docking simulations, researchers can elucidate the precise binding mechanisms and the resulting conformational changes within the receptor. Such detailed structural and functional analyses are essential for advancing our understanding of olfactory receptors and their role in sensory biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic antagonist, might modulate GPCR activity potentially affecting Olr905. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr905 signaling. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr905. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Combined alpha and beta blocker, could indirectly affect GPCR pathways including Olr905. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr905. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist, could indirectly affect Olr905 through GPCR modulation. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr905. | ||||||
Salmeterol | 89365-50-4 | sc-224277 sc-224277A | 10 mg 50 mg | $186.00 $562.00 | 1 | |
Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr905. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Beta blocker, could indirectly influence GPCR signaling pathways including Olr905. | ||||||